Compare ARK Genomic Revolution ETF (ARKG) vs First Trust NASDAQ 100 Technology Index Fund (QTEC) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs First Trust NASDAQ 100 Technology Index Fund — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while First Trust NASDAQ 100 Technology Index Fund trades at $321.04. Which is the better fit depends on your goals.
| ARKG | QTEC | |
|---|---|---|
Sector | Sector/Thematic | Broad Market / Factor |
52-Week High | $43.57 | $335.74 |
52-Week Low | $23.09 | $207.03 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
QTEC, the First Trust NASDAQ-100-Technology Sector ETF, trades at $321.04, down 0.2% on the day, with a bullish technical signal driven by moving averages and neutral oscillators. The ETF provides equal-weighted exposure to leading technology firms, tracking the Nasdaq-100 Technology Sector Index. Recent news highlights its role in broad tech exposure, with a 52-week high noted at $248.89 in April 2026, though current levels are significantly higher, indicating strong momentum.
Outlook remains positive given the ETF's focus on high-growth tech sectors, but risks include market volatility and sector concentration. Analyst sentiment is generally supportive, with institutional interest in tech diversification. Investors should weigh the ETF's performance against broader market trends and potential regulatory shifts affecting technology stocks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About First Trust NASDAQ 100 Technology Index Fund
QTEC is an ETF that seeks to track the performance of the NASDAQ-100 Technology Sector Index. The fund provides targeted exposure to companies within the NASDAQ-100 that are classified as technology or telecommunications companies, focusing on firms involved in software, hardware, and related services. QTEC is a tool for investors seeking focused exposure to high-growth, large-cap technology companies listed on the NASDAQ exchange.
Read more on QTEC →
